FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 357:91-93 July 5, 2007 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by White, C. PubMed Citation

To the Editor: In his review of intermittent claudication, White (March 22 issue)¹ emphasizes that patients with this condition are at high risk for cardiovascular events, but he does not emphasize the role of statins in this population. There is good justification for the systematic prescription of statins for patients with peripheral arterial disease. The Heart Protection Study showed that in patients with peripheral arterial disease, aggressive lowering of low-density lipoprotein cholesterol was associated with a marked reduction in cardiovascular events,² whether or not there was evidence of coronary disease at baseline; there was no apparent threshold cholesterol value below . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.